dihexa hgf c-met potentiator The HGF/c-Met Axis: A Promising Therapeutic Target in Cancer Dihexa (also known as PNB-0408)
Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect Growth factors and their peptide mimetics for treatment of traumatic brain injury ScienceDirect Evaluation of Metabolically Stabilized Angiotensin IV Analogs as Procognitive Antidementia Agents PMC
Pay in 4 interest-free payments of $7.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8


